Fourth-generation Immucillin Derivative DI4G Associated Therapy in Cutaneous Leishmaniasis
Status:
Completed
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
A clinical trial to asses efficacy and safety of Transition-state Analog Inhibitor of Human
Purine Nucleoside Phosphorylase for topical use associated standard antimonial in the
treatment of Cutaneous Leishmaniasis in Bahia, Brazil.
Phase:
Phase 2
Details
Lead Sponsor:
Hospital Universitário Professor Edgard Santos
Collaborators:
Conselho Nacional de Desenvolvimento Científico e Tecnológico Federal University of Bahia Pontificia Universidade Católica do Rio Grande do Sul